InsiderClue
Stocks · Health care · Pharmaceutical Preparations

GYRE THERAPEUTICS, INC.

GYRE Clue Score46
United States Fiscal year ends December CIK 0001124105
$7.04 +4.14% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.04 +80.51% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−20.4Net income−16.9Fiscal year 2017Revenue1.0Operating income−21.8Net income−21.6Fiscal year 2018Revenue0.0 −99.4%Operating income−33.8Net income−30.1Fiscal year 2019Operating income−57.3Net income−55.2Fiscal year 2020Revenue20.9Operating income−57.4Net income−56.2Fiscal year 2021Revenue7.3 −65.0%Operating income−87.9Net income−87.9EPS, diluted−2.87Fiscal year 2022Revenue102.3 +1,294.0%Operating income9.2Net income4.3EPS, diluted0.03Fiscal year 2023Revenue113.5 +10.9%Operating income−67.2Net income−85.5 −2,081.5%EPS, diluted−1.41Fiscal year 2024Revenue105.8 −6.8%Operating income16.2Net income17.9EPS, diluted0.05Fiscal year 2025Revenue116.6 +10.2%Operating income11.5Net income9.9 −44.8%EPS, diluted0.02
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 1.0 0.0 n/a 20.9 7.3 102.3 113.5 105.8 116.6
Growth −99.4% −65.0% +1,294.0% +10.9% −6.8% +10.2%
Operating income −20.4 −21.8 −33.8 −57.3 −57.4 −87.9 9.2 −67.2 16.2 11.5
Net income −16.9 −21.6 −30.1 −55.2 −56.2 −87.9 4.3 −85.5 17.9 9.9
Growth −2,081.5% −44.8%
EPS, diluted n/a n/a n/a n/a n/a −2.87 0.03 −1.41 0.05 0.02

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Operating margin−2,143.6%Net margin−2,118.0%Free cash flow margin−1,961.0%Fiscal year 2018Operating margin−563,700.0%Net margin−500,916.7%Free cash flow margin−482,150.0%Fiscal year 2019Fiscal year 2020Operating margin−273.9%Net margin−268.5%Fiscal year 2021Operating margin−1,197.8%Net margin−1,198.3%Free cash flow margin−1,152.8%Fiscal year 2022Gross margin95.3%Operating margin9.0%Net margin4.2%Free cash flow margin5.6%Fiscal year 2023Gross margin95.9%Operating margin−59.3%Net margin−75.3%Free cash flow margin15.3%Fiscal year 2024Gross margin96.3%Operating margin15.3%Net margin16.9%Free cash flow margin−5.6%Fiscal year 2025Operating margin9.9%Net margin8.5%Free cash flow margin−0.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a n/a 95.3% 95.9% 96.3% n/a
Operating margin n/a −2,143.6% −563,700.0% n/a −273.9% −1,197.8% 9.0% −59.3% 15.3% 9.9%
Net margin n/a −2,118.0% −500,916.7% n/a −268.5% −1,198.3% 4.2% −75.3% 16.9% 8.5%
Free cash flow margin n/a −1,961.0% −482,150.0% n/a n/a −1,152.8% 5.6% 15.3% −5.6% −0.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−18.5Capital expenditure−0.5Free cash flow−18.9Fiscal year 2017Operating cash flow−19.9Capital expenditure−0.0Free cash flow−20.0Fiscal year 2018Operating cash flow−28.6Capital expenditure−0.4Free cash flow−28.9Fiscal year 2019Operating cash flow−43.6Capital expenditure−0.1Free cash flow−43.7Fiscal year 2020Operating cash flow−55.0Fiscal year 2021Operating cash flow−83.8Capital expenditure−0.8Free cash flow−84.6Fiscal year 2022Operating cash flow10.7Capital expenditure−5.0Free cash flow5.7Dividends paid−45.0Fiscal year 2023Operating cash flow25.9Capital expenditure−8.5Free cash flow17.4 +205.3%Fiscal year 2024Operating cash flow−3.6Capital expenditure−2.3Free cash flow−6.0 −134.3%Fiscal year 2025Operating cash flow1.0Capital expenditure−1.2Free cash flow−0.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −18.5 −19.9 −28.6 −43.6 −55.0 −83.8 10.7 25.9 −3.6 1.0
Capital expenditure −0.5 −0.0 −0.4 −0.1 n/a −0.8 −5.0 −8.5 −2.3 −1.2
Free cash flow −18.9 −20.0 −28.9 −43.7 n/a −84.6 5.7 17.4 −6.0 −0.2
Growth +205.3% −134.3%
Dividends paid n/a n/a n/a n/a n/a n/a −45.0 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash10.3Shareholders’ equity16.1Fiscal year 2017Cash14.5Shareholders’ equity30.8Fiscal year 2018Cash31.2Shareholders’ equity119.9Fiscal year 2019Cash15.4Shareholders’ equity68.3Fiscal year 2020Cash30.4Shareholders’ equity76.1Fiscal year 2021Cash44.3Shareholders’ equity41.1Fiscal year 2022Cash25.2Shareholders’ equity42.5Fiscal year 2023Cash33.5Shareholders’ equity−15.8Fiscal year 2024Cash11.8Shareholders’ equity63.3Fiscal year 2025Cash37.1Shareholders’ equity106.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 10.3 14.5 31.2 15.4 30.4 44.3 25.2 33.5 11.8 37.1
Shareholders’ equity 16.1 30.8 119.9 68.3 76.1 41.1 42.5 −15.8 63.3 106.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 1.0 0.0 n/a 20.9 7.3 102.3 113.5 105.8 116.6
Growth −99.4% −65.0% +1,294.0% +10.9% −6.8% +10.2%
n/a n/a n/a n/a n/a n/a 4.8 4.6 3.9 5.4
n/a n/a n/a n/a n/a n/a 97.5 108.8 101.9 n/a
Growth +11.6% −6.4%
11.6 12.8 21.5 43.9 53.0 68.9 n/a 13.8 12.0 13.7
9.3 10.0 12.4 13.4 16.2 19.0 17.4 14.7 16.1 20.8
−20.4 −21.8 −33.8 −57.3 −57.4 −87.9 9.2 −67.2 16.2 11.5
Growth −830.5% −28.9%
n/a n/a n/a n/a n/a −87.9 9.4 −77.0 23.2 14.4
n/a n/a n/a n/a n/a n/a 5.1 8.5 5.3 4.6
−16.9 −21.6 −30.1 −55.2 −56.2 −87.9 4.3 −85.5 17.9 9.9
Growth −2,081.5% −44.8%
Per share
n/a n/a n/a n/a n/a −2.87 0.04 −1.41 0.14 0.06
n/a n/a n/a n/a n/a −2.87 0.03 −1.41 0.05 0.02
Growth −4,800.0% −60.0%
n/a n/a n/a n/a n/a 30.6 63.6 65.8 85.1 89.3
n/a n/a n/a n/a n/a 30.6 75.7 65.8 102.3 103.2
Growth +147.0% −13.0% +55.4% +0.9%

† The diluted share count jumps at 2022 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 41.0% a year over five years.
  • Operating margin is up 283.7 points on five years ago, at 9.9%.
  • A net loss in 7 of 10 years on file.